Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) Margin of Safety % (DCF Earnings Based): N/A (As of Sep. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688393 Guangzhou LBP Medicine Science & Technology Co Ltd SHSE:688393
63 GF Score
Price ¥18.79
GF Value ¥33.60
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Guangzhou LBP Medicine Science & Technology Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Guangzhou LBP Medicine Science & Technology Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SHSE:688393 vs ISRG, BDX, RMD: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Instruments & Supplies subindustry, Guangzhou LBP Medicine Science & Technology Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangzhou LBP Medicine Science & Technology Co Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guangzhou LBP Medicine Science & Technology Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Guangzhou LBP Medicine Science & Technology Co's Margin of Safety % (DCF Earnings Based) falls into.


SHSE:688393
63GF Score
Guangzhou LBP Medicine Science & Technology Co Ltd SHSE:688393
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou LBP Medicine Science & Technology Co stock appears to be undervalued. The current stock price of ¥18.79 is trading 44.1% below its estimated GF Value™ of ¥33.60. GuruFocus considers Guangzhou LBP Medicine Science & Technology Co to be Significantly Undervalued.

Key valuation signals for SHSE:688393:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥33.60 vs. price of ¥18.79 (44.1% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688393 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangzhou LBP Medicine Science & Technology Co Business Description

Address Building 7, No. 11, Nanxiang 3rd Road, Guangzhou High-tech Industrial Development Zone, Guangdong Province, Guangzhou, CHN, 510663
Guangzhou LBP Medicine Science & Technology Co Ltd is engaged in production and sales of in vitro diagnostic reagents and instruments. The company's products include Fluorescence in situ hybridization (FISH) series; Immunohistochemistry (IHC) series; Liquid - based cytology (LBP) series; PCR series; and medical laboratory.
63GF Score

Get the complete analysis for SHSE:688393

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.79
Price
¥33.60
GF Value